Lung disease test done by AI to be rolled out in GP surgeries - ‘Game-changing’ AI-driven lung test set for GP surgery ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Decreased levels of resolvin D1 are linked to prolonged respiratory symptoms and slower clinical recovery in patients with ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas -- tiny clumps of immune cells that form in response to inflammation. It's the most inflammatory of the interstitial lung diseases ...

Research Pinpoints Weakness in Lung Cancer's Defenses Feb ... the lungs as people take a breath in patients with asthma, chronic obstructive pulmonary disease (COPD), and ...

Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...

A new study finds that KL-6 and hSP-D levels can help predict progression of interstitial lung disease in patients with ...

Plasma-based molecular residual disease analysis shows the potential to predict disease recurrence in lung cancer patients by 4.7 months.

Due to the destructive nature of COPD on patients’ lungs and well-being, timely diagnosis is key, and integrating spirometry ...

The CDC unit that dramatically reduced Black Lung Disease among coal miners has been fired in Trump's sweeping overhaul of ...

OS for osimertinib vs placebo was 58.8 vs 54 months at the latest analysis of the phase 3 LAURA trial, according to ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...